40-Year CHD Mortality Trends and the Role of Risk Factors in Mortality Decline: The North Karelia Project Experience

Global Heart

Volumn 11, Issue 2, 2016, Pages 207-212

  Jousilahti, Pekka ^a   Laatikainen, Tiina ^b   Salomaa, Veikko ^a   Pietilä, Arto ^a   Vartiainen, Erkki ^a   Puska, Pekka ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; FINLAND; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY RISK; PRIORITY JOURNAL; REVIEW; RISK FACTOR; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; FORECASTING; MORTALITY; PROCEDURES; PUBLIC HEALTH; RISK ASSESSMENT; SURVIVAL RATE; TRENDS;

CARDIOVASCULAR DISEASES; FINLAND; FORECASTING; PUBLIC HEALTH; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 85008698374     PISSN: 22118160     EISSN: 22118179     Source Type: Journal    
DOI: 10.1016/j.gheart.2016.04.004     Document Type: Review

References (34)

1. 1 GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385 (2015), 117–171.
2. 2 Thom, T.J., Epstein, F.H., Feldman, J.J., Leaverton, P.E., Wolz, M., Total Mortality and Mortality From Heart Disease, Cancer and Stroke From 1950 to 1987 in 27 Countries. NIH Publications No. 92-3088. 1992, National Institute of Health, Bethesda, MD.
3. 3 Doll, R., Hill, A.B., The mortality of doctors in relation to their smoking habits: a preliminary report. Br Med J 1 (1954), 1451–1455.
4. 4 Kannel, W.B., Dawber, T.R., Kagan, A., Revotskie, N., Stokes, J. 3rd, Factors of risk in the development of coronary heart disease—six year follow-up experience: the Framingham Study. Ann Intern Med 55 (1961), 33–50.
5. 5 Keys, A., Blackburn, H., Menotti, A., et al. Coronary Heart Disease in Seven Countries. Circulation 41 (1970), 1–211.
6. 6 Doll, R., Peto, R., Boreham, J., Sutherland, I., Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ, 328, 2004, 1519.
7. 7 Lewington, S., Clarke, R., Qizilbash, N., et al., for the Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002), 1903–1913.
8. 8 Lewington, S., Whitlock, G., Clarke, R., et al., for the Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 370 (2007), 1829–1839.
9. 9 Keys, A., Anderson, J.T., Grande, F., Serum cholesterol response to changes in the diet: IV. Particular saturated fatty acids in the diet. Metabolism 14 (1965), 776–787.
10. 10 Rose, G., Stamler, J., for the INTERSALT Co-operative Research Group. The INTERSALT study: background, methods and main results. J Hum Hypertens 3 (1989), 283–288.
11. 11 Puska, P., Nissinen, A., Tuomilehto, J., et al. The community-based strategy to prevent coronary health disease: conclusions from the ten years of the North Karelia Project. Annu Rev Public Health 6 (1985), 147–193.
12. 12 Puska, P., Vartiainen, E., Laatikainen, T., Jousilahti, P., Paavola, M., (eds.) The North Karelia Project: From North Karelia to National Action. National Institute for Health and Welfare (THL), in collaboration with the North Karelia Project Foundation, 2009, Helsinki University Printing House, Helsinki.
13. 13 Borodulin, K., Vartiainen, E., Peltonen, M., et al. Forty-year trends in cardiovascular risk factors in Finland. Eur J Public Health 25 (2015), 539–546.
14. 14 Vartiainen, E., Puska, P., Pekkanen, J., Tuomilehto, J., Jousilahti, P., Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 309 (1994), 23–27.
15. 15 Jousilahti, P., Laatikainen, T., Peltonen, M., et al. Forty-year change in coronary heart disease mortality among working aged men and women in Eastern Finland: the role of primary prevention and risk factor reduction. BMJ, 352, 2016, i721.
16. 16 WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (Monitoring Trends and Determinants in Cardiovascular Disease): a major international collaboration. J Clin Epidemiol 41 (1988), 105–114.
17. 17 Sundvall, J., Leiviskä, J., Alfthan, G., Vartiainen, E., Serum cholesterol during 27 years: assessment of systematic error and affecting factors and their role in interpreting population trends. Clin Chim Acta 378 (2007), 93–98.
18. 18 Whitlock, G., Lewington, S., Sherliker, P., et al., for the Prospective Studies Collaboration. Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies. Lancet 373 (2009), 1083–1096.
19. 19 Sarwar, N., Gao, P., Seshasai, S.R., et al., for the Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 375 (2010), 2215–2222.
20. 20 Malyutina, S., Bobak, M., Kurilovitch, S., et al. Relation between heavy and binge drinking and all-cause and cardiovascular mortality in Novosibirsk, Russia: a prospective cohort study. Lancet 360 (2002), 1448–1454.
21. 21 Borodulin, K., Harald, K., Jousilahti, P., Laatikainen, T., Männistö, S., Vartiainen, E., Time trends in physical activity from 1982 to 2012 in Finland. Scand J Med Sci Sports 26 (2016), 93–100.
22. 22 Graham, I., Atar, D., Borch-Johnsen, K., et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil 14:Suppl 2 (2007), S1–S113.
23. 23 Salomaa, V., Havulinna, A.S., Koukkunen, H., et al. Aging of the population may not lead to an increase in the numbers of acute coronary events: a community surveillance study and modelled forecast of the future. Heart 99 (2013), 954–959.
24. 24 Mähönen, M., Pietilä, A., Havulinna, A.S., et al. Sepelvaltimotaudin kajoavia toimenpiteitä koskevien rekisteritietojen luotettavuus ja kehityssuunnat 1994–2011. Suomen Lääkärilehti 69 (2014), 1953–1958.
25. 25 Laatikainen, T., Critchley, J., Vartiainen, E., Salomaa, V., Ketonen, M., Capewell, S., Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 162 (2005), 764–773.
26. 26 Kannisto, V., Kuolemansyyt väestöllisinä tekijöinä Suomessa. Kansantaloudellisia tutkimuksia 17. Helsinki, 1947.
27. 27 Ganesh, S.K., Arnett, D.K., Assimes, T.L., et al. Genetics and genomics for the prevention and treatment of cardiovascular disease: update: a scientific statement from the American Heart Association. Circulation 128 (2013), 2813–2851.
28. 28 Surakka, I., Kristiansson, K., Anttila, V., et al. Founder population-specific HapMap panel increases power in GWA studies through improved imputation accuracy and CNV tagging. Genome Res 20 (2010), 1344–1351.
29. 29 Jousilahti, P., Puska, P., Vartiainen, E., Pekkanen, J., Tuomilehto, J., Parental history of premature coronary heart disease; an independent risk factor of myocardial infarction. J Clin Epidemiol 49 (1996), 497–503.
30. 30 Jousilahti, P., Vartiainen, E., Tuomilehto, J., Pekkanen, J., Puska, P., Role of known risk factors in explaining the difference in the risk of coronary heart disease between eastern and southwestern Finland. Ann Med 30 (1998), 481–487.
31. 31 Jousilahti, P., Salomaa, V., Kuulasmaa, K., Niemelä, M., Vartiainen, E., Total and cause specific mortality among participants and non-participants of population-based health surveys: a comprehensive follow-up of 54,372 Finnish men and women. J Epidemiol Community Health 59 (2005), 310–315.
32. 32 Barnett, A.G., van der Pols, J.C., Dobson, A.J., Regression to the mean: what it is and how to deal with it. Int J Epidemiol 34 (2005), 215–220.
33. 33 Jousilahti, P., Vartiainen, E., Korhonen, H.J., Puska, P., Tuomilehto, J., Is the effect of smoking on the risk for coronary heart disease even stronger than was previously thought?. J Cardiovasc Risk 6 (1999), 293–298.
34. 34 World Health Organization. Global Action Plan for the Prevention and Control of Non-Communicable Diseases 2014–2020. 2013, World Health Organization, Geneva, Switzerland.